HPS Pharmacies wish to advise that Perrigo is continuing to experience a supply interruption for Fentanyl Intranasal as follows:
This supply interruption is due to machinery requiring repair by the overseas-based manufacturer. While an additional batch was manufactured to cover the expected machine downtime, this batch failed quality assurance and compliance review and was unable to be distributed.
Normal supplies of Fentanyl Intranasal are expected to resume in the week commencing 13 March 2023.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Perrigo on 1800 805 546, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates